Source: New York Times
Date: June 7, 2007
Summary:
The New York Times reports on both the potential benefits and risks of new method of turning a skin cell of a mouse back to an embryonic state.
"While intriguing, a new approach for producing embryonic stem cells faces considerable hurdles before it can be used to develop medical treatments, executives from stem cell and other biotechnology companies said yesterday. In particular, they said, the technique involves genetically altering cells, which could introduce new safety risks and make it harder to obtain regulatory approval."
